Literature DB >> 2866948

Drug treatment of obsessive-compulsive disorder.

P T Lelliott, W O Monteiro.   

Abstract

Obsessive-compulsive disorder (OCD) is an uncommon but difficult to manage problem. Behaviour therapy is the treatment of choice, with clomipramine as an adjunct in patients with coexisting depression. However, the incidence of side effects with the doses required (up to 200 mg daily, or occasionally higher) is high, and the side effects may be intolerable to some patients. Benzodiazepines have no effect on the core symptoms of OCD, and their usefulness as long term anxiolytics is outweighed by the risks of physical and psychological dependence. There is no place for antipsychotic drugs in managing obsessive-compulsive disorder.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2866948     DOI: 10.2165/00003495-198631010-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  11 in total

1.  OBSESSIONAL NEUROTICS: A LONG-TERM FOLLOW-UP.

Authors:  E KRINGLEN
Journal:  Br J Psychiatry       Date:  1965-08       Impact factor: 9.319

2.  Success and failure in the behavioral treatment of obsessive-compulsives.

Authors:  E B Foa; J B Grayson; G S Steketee; H G Doppelt; R M Turner; P R Latimer
Journal:  J Consult Clin Psychol       Date:  1983-04

3.  Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial.

Authors:  W O Monteiro; H F Noshirvani; I M Marks; P T Lelliott
Journal:  Br J Psychiatry       Date:  1987-07       Impact factor: 9.319

4.  A cross-national comparison of anti-anxiety/sedative drug use.

Authors:  M B Balter; D I Manheimer; G D Mellinger; E H Uhlenhuth
Journal:  Curr Med Res Opin       Date:  1984       Impact factor: 2.580

5.  Clomipramine and exposure for obsessive-compulsive rituals: i.

Authors:  I M Marks; R S Stern; D Mawson; J Cobb; R McDonald
Journal:  Br J Psychiatry       Date:  1980-01       Impact factor: 9.319

6.  Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects.

Authors:  P Thorén; M Asberg; L Bertilsson; B Mellström; F Sjöqvist; L Träskman
Journal:  Arch Gen Psychiatry       Date:  1980-11

7.  Obsessive-compulsive disorder and primary unipolar depression. Comparisons of background, family history, course, and mortality.

Authors:  W Coryell
Journal:  J Nerv Ment Dis       Date:  1981-04       Impact factor: 2.254

8.  Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.

Authors:  T R Insel; D L Murphy; R M Cohen; I Alterman; C Kilts; M Linnoila
Journal:  Arch Gen Psychiatry       Date:  1983-06

Review 9.  Are there anticompulsive or antiphobic drugs? Review of the evidence.

Authors:  I Marks
Journal:  Br J Psychiatry       Date:  1983-10       Impact factor: 9.319

10.  Clomipramine and exposure for chronic obsessive-compulsive rituals: III. Two year follow-up and further findings.

Authors:  D Mawson; I M Marks; L Ramm
Journal:  Br J Psychiatry       Date:  1982-01       Impact factor: 9.319

View more
  1 in total

Review 1.  Assessing the validity of current mouse genetic models of obsessive-compulsive disorder.

Authors:  Li Wang; Helen B Simpson; Stephanie C Dulawa
Journal:  Behav Pharmacol       Date:  2009-03       Impact factor: 2.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.